(President & CEO: Izumi Oi) has developed the "LazEdge", an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the ...
BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) said on Tuesday it has completed enrollment in its ADDRESS-LC Phase 2 clinical trial ...
Data from Phase 1b dose escalation and expansion trial (n=69) shows a favorable safety profile, with manageable adverse events consistent with ...
Subset analysis shows early clinical activity supported by biomarker evidence of targeting cancer stem cell pathways driving tumor growth and ...
While retatrutide may have the best weight loss efficacy to date, analysts hold concerns about its tolerability profile compared with best-seller, tirzepatide.
MB097 used in combination with MSD’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab)CAMBRIDGE, United Kingdom, May 18, 2026 ...
Study Published in Advances in Redox Research Demonstrated Dose-Dependent Survival Improvement, Reduced Hepatic Copper ...
Three digital multiphase controllers from AOS enable Intel IMVP9.3 Vcore power delivery for high-performance mobile systems.
The new devices, the STDRIVE102P and STDRIVE102BP, are part of the STDRIVE102 series for three-phase brushless motors. Both ...
Allan Young and King’s College, London First time a Selective Endocannabinoid Reuptake Inhibitor (SERI) molecule is dosed in ...
Detailed price information for Aptevo Therapeutics Inc (APVO-Q) from The Globe and Mail including charting and trades.
EEST Herantis Pharma partners with Indivi to enable detection of early treatment effects in upcoming HER-096 Phase 2 trial in Parkinson's disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results